Affiliation:
1. Lung Immunology Group, Section of Infectious Diseases and Immunity, Hammersmith Campus, Department of Medicine, Centre for Respiratory Infection, Imperial College London, London, UK
2. Department of Respiratory Medicine, Royal Brompton & Harefield NHS Trust, London, UK
Abstract
Summary
Recent studies analysing immunogenetics and immune mechanisms controlling susceptibility to chronic bacterial infection in bronchiectasis implicate dysregulated immunity in conjunction with chronic bacterial infection. Bronchiectasis is a structural pathological end-point with many causes and disease associations. In about half of cases it is termed idiopathic, because it is of unknown aetiology. Bronchiectasis is proposed to result from a ‘vicious cycle’ of chronic bacterial infection and dysregulated inflammation. Paradoxically, both immune deficiency and excess immunity, either in the form of autoimmunity or excessive inflammatory activation, can predispose to disease. It appears to be a part of the spectrum of inflammatory, autoimmune and atopic conditions that have increased in prevalence through the 20th century, attributed variously to the hygiene hypothesis or the ‘missing microbiota’. Immunogenetic studies showing a strong association with human leucocyte antigen (HLA)-Cw*03 and HLA-C group 1 homozygosity and combinational analysis of HLA-C and killer immunoglobulin-like receptors (KIR) genes suggests a shift towards activation of natural killer (NK) cells leading to lung damage. The association with HLA-DR1, DQ5 implicates a role for CD4 T cells, possibly operating through influence on susceptibility to specific pathogens. We hypothesize that disruption of the lung microbial ecosystem, by infection, inflammation and/or antibiotic therapy, creates a disturbed, simplified, microbial community (‘disrupted microbiota’) with downstream consequences for immune function. These events, acting with excessive NK cell activation, create a highly inflammatory lung environment that, in turn, permits the further establishment and maintenance of chronic infection dominated by microbial pathogens. This review discusses the implication of these concepts for the development of therapeutic interventions.
Funder
Welton Foundation
Royal Brompton and Harefield NHS Trust Clinical Research Committee
BBSRC
NIH
MRC
Publisher
Oxford University Press (OUP)
Subject
Immunology,Immunology and Allergy
Reference44 articles.
1. Pulmonary defences to acute respiratory infection;Boyton;Br Med Bull,2002
2. Structure, function and diversity of the healthy human microbiome;Human Microbiome Project Consortium;Nature,2012
3. Bronchiectasis;Boyton;Medicine,2012
4. A new look at the pathogenesis and management of persistent bronchial sepsis: a ‘vicious circle’ hypothesis and its logical therapeutical connotations;Cole,1984
5. TAP deficiency syndrome;Gadola;Clin Exp Immunol,2000
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献